And in the case of the latest wave of weight loss drugs, right now at their ... or Ozempic two years later. And in a Blue Cross Blue Shield Association white paper posted last summer, the number ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent pharmaceutical advances have led to the development of weight loss drugs.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Weight-loss drugs like Ozempic may offer health benefits far beyond those already flagged by research, a large-scale study suggests. Scientists probing the health records of nearly 216,000 people ...

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...